Therapeutic potential of PRMT1 as a critical survival dependency target in multiple myeloma.

Saved in:
Bibliographic Details
Title: Therapeutic potential of PRMT1 as a critical survival dependency target in multiple myeloma.
Authors: Hussain T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1901 East Rd, Houston, TX, 77054, USA., Awasthi S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1901 East Rd, Houston, TX, 77054, USA., Shahid F; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1901 East Rd, Houston, TX, 77054, USA.; National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD, USA., Yi SS; Baylor Research Institute and Baylor College of Medicine, Temple, TX, USA., Sahni N; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1901 East Rd, Houston, TX, 77054, USA.; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Quantative and Computational Biosciences Program, Baylor College of Medicine, Houston, TX, USA., Aldaz CM; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, 1901 East Rd, Houston, TX, 77054, USA. maaldaz@mdanderson.org.
Source: BMC cancer [BMC Cancer] 2025 Nov 04; Vol. 25 (1), pp. 1704. Date of Electronic Publication: 2025 Nov 04.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first